Product Information
BUDESONIDE ER 9 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $14.2105 per EA under NDC 00591251030. Its NADAC has been published 402 times since Oct 17, 2018.
Strength
9 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591251030
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205457On Market Since
7/5/2018
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE ER 9 MG TABLET has been published 402 times since Oct 17, 2018, and over the history we have for it it has declined 66.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.2105 per EA |
|---|---|
| All-time high | $44.5486 (Dec 12, 2018) |
| All-time low | $11.9909 (May 20, 2026) |
| 52-week high | $18.6414 |
| 52-week low | $11.9909 |
| Median price | $31.2903 |
| Average price | $28.8136 |
| Largest weekly change | -35.3% (Apr 17, 2024) |
| Weeks tracked | 402 |
| Tracking since | Oct 17, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUDESONIDE ER 9 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE ER 9 MG TABLET, manufactured by Actavis Pharma, Inc., is $14.2105 per EA (NDC 00591251030), effective Jun 24, 2026.
How has the price of BUDESONIDE ER 9 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUDESONIDE ER 9 MG TABLET has declined 66.3%. It has been tracked across 402 weekly CMS publications since Oct 17, 2018.
What are the highest and lowest recorded NADAC prices for BUDESONIDE ER 9 MG TABLET?
Since Oct 17, 2018, the NADAC for BUDESONIDE ER 9 MG TABLET has ranged from a low of $11.9909 (May 20, 2026) to a high of $44.5486 (Dec 12, 2018), with a median of $31.2903 per EA.
Are there cheaper alternatives to BUDESONIDE ER 9 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BUDESONIDE ER 9 MG TABLET, but none are currently priced below it.
Who manufactures BUDESONIDE ER 9 MG TABLET?
BUDESONIDE ER 9 MG TABLET (NDC 00591251030) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification